Here’s a glimpse of the services that you may benefit from.
- Access to unique research models, such as Patient-derived xenografts and Polycystic kidney disease models
- IACUC and veterinary support
- Safety, tolerability and toxicology
- PK/PD studies
- Animal and supply management
- Dosing and animal handling
- Tissue and organ dissections
- Cryopreservation
- Necropsy
- Surgery
Additional support and guidance:
- Scientific support
- Analysis and interpretation of data
- Study preparation
- Access to our in vivo analysis systems
Curious about more information on our ISAP program?
Contact our expert Pascal for an outline of the program possibilities for your upcoming project.Want to read more?
Accelerating Angelman Syndrome Research: InnoSer now offers Angelman Syndrome Mouse Model
As part of our ongoing efforts to support the development of new therapeutics for rare genetic neurological diseases, we are proud to introduce a new preclinical research model for Angelman Syndrome within InnoSer’s portfolio. In collaboration with Professor Ype...
InnoSer Partners with Kabuki Syndrome Foundation to Advance Therapeutic Development for Kabuki Syndrome
InnoSer to serve as the central hub for Kabuki Syndrome Foundation-funded preclinical research in the Kmt2d+/βGeo mouse model. This collaboration aims to empower leading biotech and pharma innovators to perform rigorous studies informing clinical trial readiness of...
InnoSer Presents New Data on Tau[P301S] and α-Synuclein Combination Models for Neurodegenerative Research at ADPD 2025
We are excited to announce that InnoSer, as an innovative European preclinical neurodegenerative disease CRO, will be actively participating in the upcoming ADPD 2025 conference, taking place in Vienna, Austria from 1st to 5th April 2025. The ADPD 2025 Conference is...